世界の治療用血漿交換市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Therapeutic Plasma Exchange Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5618 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、治療用血漿交換のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（神経障害、腎障害、血液疾患、代謝障害、その他）、用途別市場規模（病院、専門クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・治療用血漿交換の市場動向 ・企業の競争状況、市場シェア ・治療用血漿交換の種類別市場規模（神経障害、腎障害、血液疾患、代謝障害、その他） ・治療用血漿交換の用途別市場規模（病院、専門クリニック、外来手術センター） ・治療用血漿交換の北米市場規模2016-2027（アメリカ、カナダ） ・治療用血漿交換のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・治療用血漿交換のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・治療用血漿交換の中南米市場規模2016-2027（メキシコ、ブラジル） ・治療用血漿交換の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Asahi Kasei Corporation、Baxter International、Terumo Corporation、B. Braun、Fresenius Kabi、Kawasumi Laboratories、Haemonetics Corporation、Cerus Corporation、Hemacare Corporation、Medica S.p.A.） ・結論

Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely performed in the treatment of various chronic diseases as first line or as second line of therapy or as a supportive treatment.
Therapeutic plasma exchange (TPE) has wide applications in the treatment of neurological, renal, hematological, and metabolic disorders. The indications for using therapeutic plasma exchange procedures as a line of treatment are regulated through guidelines provided by the American Society for Apheresis (ASFA). It categorizes the indications in four parts: category I to IV. Category I and II depict TPE as first or second line of treatment for many neurological, renal, and hematological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura (TTP).

Market Analysis and Insights: Global Therapeutic Plasma Exchange Market
The global Therapeutic Plasma Exchange market size is projected to reach US$ 326.3 million by 2026, from US$ 173.7 million in 2019, at a CAGR of 9.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Therapeutic Plasma Exchange market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Therapeutic Plasma Exchange market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Therapeutic Plasma Exchange market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Therapeutic Plasma Exchange market.

Global Therapeutic Plasma Exchange Scope and Market Size
Therapeutic Plasma Exchange market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Plasma Exchange market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Neurological Disorders
Renal Disorders
Hematology Disorders
Metabolic Disorders
Others

Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Asahi Kasei Corporation
Baxter International
Terumo Corporation
B. Braun
Fresenius Kabi
Kawasumi Laboratories
Haemonetics Corporation
Cerus Corporation
Hemacare Corporation

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Plasma Exchange Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Neurological Disorders
1.2.3 Renal Disorders
1.2.4 Hematology Disorders
1.2.5 Metabolic Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Therapeutic Plasma Exchange Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Therapeutic Plasma Exchange Market Perspective (2016-2027)
2.2 Therapeutic Plasma Exchange Growth Trends by Regions
2.2.1 Therapeutic Plasma Exchange Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Therapeutic Plasma Exchange Historic Market Share by Regions (2016-2021)
2.2.3 Therapeutic Plasma Exchange Forecasted Market Size by Regions (2022-2027)
2.3 Therapeutic Plasma Exchange Industry Dynamic
2.3.1 Therapeutic Plasma Exchange Market Trends
2.3.2 Therapeutic Plasma Exchange Market Drivers
2.3.3 Therapeutic Plasma Exchange Market Challenges
2.3.4 Therapeutic Plasma Exchange Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Plasma Exchange Players by Revenue
3.1.1 Global Top Therapeutic Plasma Exchange Players by Revenue (2016-2021)
3.1.2 Global Therapeutic Plasma Exchange Revenue Market Share by Players (2016-2021)
3.2 Global Therapeutic Plasma Exchange Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Plasma Exchange Revenue
3.4 Global Therapeutic Plasma Exchange Market Concentration Ratio
3.4.1 Global Therapeutic Plasma Exchange Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Plasma Exchange Revenue in 2020
3.5 Therapeutic Plasma Exchange Key Players Head office and Area Served
3.6 Key Players Therapeutic Plasma Exchange Product Solution and Service
3.7 Date of Enter into Therapeutic Plasma Exchange Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Therapeutic Plasma Exchange Breakdown Data by Type
4.1 Global Therapeutic Plasma Exchange Historic Market Size by Type (2016-2021)
4.2 Global Therapeutic Plasma Exchange Forecasted Market Size by Type (2022-2027)

5 Therapeutic Plasma Exchange Breakdown Data by Application
5.1 Global Therapeutic Plasma Exchange Historic Market Size by Application (2016-2021)
5.2 Global Therapeutic Plasma Exchange Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Therapeutic Plasma Exchange Market Size (2016-2027)
6.2 North America Therapeutic Plasma Exchange Market Size by Type
6.2.1 North America Therapeutic Plasma Exchange Market Size by Type (2016-2021)
6.2.2 North America Therapeutic Plasma Exchange Market Size by Type (2022-2027)
6.2.3 North America Therapeutic Plasma Exchange Market Size by Type (2016-2027)
6.3 North America Therapeutic Plasma Exchange Market Size by Application
6.3.1 North America Therapeutic Plasma Exchange Market Size by Application (2016-2021)
6.3.2 North America Therapeutic Plasma Exchange Market Size by Application (2022-2027)
6.3.3 North America Therapeutic Plasma Exchange Market Size by Application (2016-2027)
6.4 North America Therapeutic Plasma Exchange Market Size by Country
6.4.1 North America Therapeutic Plasma Exchange Market Size by Country (2016-2021)
6.4.2 North America Therapeutic Plasma Exchange Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Therapeutic Plasma Exchange Market Size (2016-2027)
7.2 Europe Therapeutic Plasma Exchange Market Size by Type
7.2.1 Europe Therapeutic Plasma Exchange Market Size by Type (2016-2021)
7.2.2 Europe Therapeutic Plasma Exchange Market Size by Type (2022-2027)
7.2.3 Europe Therapeutic Plasma Exchange Market Size by Type (2016-2027)
7.3 Europe Therapeutic Plasma Exchange Market Size by Application
7.3.1 Europe Therapeutic Plasma Exchange Market Size by Application (2016-2021)
7.3.2 Europe Therapeutic Plasma Exchange Market Size by Application (2022-2027)
7.3.3 Europe Therapeutic Plasma Exchange Market Size by Application (2016-2027)
7.4 Europe Therapeutic Plasma Exchange Market Size by Country
7.4.1 Europe Therapeutic Plasma Exchange Market Size by Country (2016-2021)
7.4.2 Europe Therapeutic Plasma Exchange Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Plasma Exchange Market Size (2016-2027)
8.2 Asia-Pacific Therapeutic Plasma Exchange Market Size by Type
8.2.1 Asia-Pacific Therapeutic Plasma Exchange Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Therapeutic Plasma Exchange Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Therapeutic Plasma Exchange Market Size by Type (2016-2027)
8.3 Asia-Pacific Therapeutic Plasma Exchange Market Size by Application
8.3.1 Asia-Pacific Therapeutic Plasma Exchange Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Therapeutic Plasma Exchange Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Therapeutic Plasma Exchange Market Size by Application (2016-2027)
8.4 Asia-Pacific Therapeutic Plasma Exchange Market Size by Region
8.4.1 Asia-Pacific Therapeutic Plasma Exchange Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Therapeutic Plasma Exchange Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Therapeutic Plasma Exchange Market Size (2016-2027)
9.2 Latin America Therapeutic Plasma Exchange Market Size by Type
9.2.1 Latin America Therapeutic Plasma Exchange Market Size by Type (2016-2021)
9.2.2 Latin America Therapeutic Plasma Exchange Market Size by Type (2022-2027)
9.2.3 Latin America Therapeutic Plasma Exchange Market Size by Type (2016-2027)
9.3 Latin America Therapeutic Plasma Exchange Market Size by Application
9.3.1 Latin America Therapeutic Plasma Exchange Market Size by Application (2016-2021)
9.3.2 Latin America Therapeutic Plasma Exchange Market Size by Application (2022-2027)
9.3.3 Latin America Therapeutic Plasma Exchange Market Size by Application (2016-2027)
9.4 Latin America Therapeutic Plasma Exchange Market Size by Country
9.4.1 Latin America Therapeutic Plasma Exchange Market Size by Country (2016-2021)
9.4.2 Latin America Therapeutic Plasma Exchange Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Plasma Exchange Market Size (2016-2027)
10.2 Middle East & Africa Therapeutic Plasma Exchange Market Size by Type
10.2.1 Middle East & Africa Therapeutic Plasma Exchange Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Therapeutic Plasma Exchange Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Therapeutic Plasma Exchange Market Size by Type (2016-2027)
10.3 Middle East & Africa Therapeutic Plasma Exchange Market Size by Application
10.3.1 Middle East & Africa Therapeutic Plasma Exchange Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Therapeutic Plasma Exchange Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Therapeutic Plasma Exchange Market Size by Application (2016-2027)
10.4 Middle East & Africa Therapeutic Plasma Exchange Market Size by Country
10.4.1 Middle East & Africa Therapeutic Plasma Exchange Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Therapeutic Plasma Exchange Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Asahi Kasei Corporation
11.1.1 Asahi Kasei Corporation Company Details
11.1.2 Asahi Kasei Corporation Business Overview
11.1.3 Asahi Kasei Corporation Therapeutic Plasma Exchange Introduction
11.1.4 Asahi Kasei Corporation Revenue in Therapeutic Plasma Exchange Business (2016-2021)
11.1.5 Asahi Kasei Corporation Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Details
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Therapeutic Plasma Exchange Introduction
11.2.4 Baxter International Revenue in Therapeutic Plasma Exchange Business (2016-2021)
11.2.5 Baxter International Recent Development
11.3 Terumo Corporation
11.3.1 Terumo Corporation Company Details
11.3.2 Terumo Corporation Business Overview
11.3.3 Terumo Corporation Therapeutic Plasma Exchange Introduction
11.3.4 Terumo Corporation Revenue in Therapeutic Plasma Exchange Business (2016-2021)
11.3.5 Terumo Corporation Recent Development
11.4 B. Braun
11.4.1 B. Braun Company Details
11.4.2 B. Braun Business Overview
11.4.3 B. Braun Therapeutic Plasma Exchange Introduction
11.4.4 B. Braun Revenue in Therapeutic Plasma Exchange Business (2016-2021)
11.4.5 B. Braun Recent Development
11.5 Fresenius Kabi
11.5.1 Fresenius Kabi Company Details
11.5.2 Fresenius Kabi Business Overview
11.5.3 Fresenius Kabi Therapeutic Plasma Exchange Introduction
11.5.4 Fresenius Kabi Revenue in Therapeutic Plasma Exchange Business (2016-2021)
11.5.5 Fresenius Kabi Recent Development
11.6 Kawasumi Laboratories
11.6.1 Kawasumi Laboratories Company Details
11.6.2 Kawasumi Laboratories Business Overview
11.6.3 Kawasumi Laboratories Therapeutic Plasma Exchange Introduction
11.6.4 Kawasumi Laboratories Revenue in Therapeutic Plasma Exchange Business (2016-2021)
11.6.5 Kawasumi Laboratories Recent Development
11.7 Haemonetics Corporation
11.7.1 Haemonetics Corporation Company Details
11.7.2 Haemonetics Corporation Business Overview
11.7.3 Haemonetics Corporation Therapeutic Plasma Exchange Introduction
11.7.4 Haemonetics Corporation Revenue in Therapeutic Plasma Exchange Business (2016-2021)
11.7.5 Haemonetics Corporation Recent Development
11.8 Cerus Corporation
11.8.1 Cerus Corporation Company Details
11.8.2 Cerus Corporation Business Overview
11.8.3 Cerus Corporation Therapeutic Plasma Exchange Introduction
11.8.4 Cerus Corporation Revenue in Therapeutic Plasma Exchange Business (2016-2021)
11.8.5 Cerus Corporation Recent Development
11.9 Hemacare Corporation
11.9.1 Hemacare Corporation Company Details
11.9.2 Hemacare Corporation Business Overview
11.9.3 Hemacare Corporation Therapeutic Plasma Exchange Introduction
11.9.4 Hemacare Corporation Revenue in Therapeutic Plasma Exchange Business (2016-2021)
11.9.5 Hemacare Corporation Recent Development
11.10 Medica S.p.A.
11.10.1 Medica S.p.A. Company Details
11.10.2 Medica S.p.A. Business Overview
11.10.3 Medica S.p.A. Therapeutic Plasma Exchange Introduction
11.10.4 Medica S.p.A. Revenue in Therapeutic Plasma Exchange Business (2016-2021)
11.10.5 Medica S.p.A. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Therapeutic Plasma Exchange Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Neurological Disorders
Table 3. Key Players of Renal Disorders
Table 4. Key Players of Hematology Disorders
Table 5. Key Players of Metabolic Disorders
Table 6. Key Players of Others
Table 7. Global Therapeutic Plasma Exchange Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Therapeutic Plasma Exchange Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Therapeutic Plasma Exchange Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Therapeutic Plasma Exchange Market Share by Regions (2016-2021)
Table 11. Global Therapeutic Plasma Exchange Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Therapeutic Plasma Exchange Market Share by Regions (2022-2027)
Table 13. Therapeutic Plasma Exchange Market Trends
Table 14. Therapeutic Plasma Exchange Market Drivers
Table 15. Therapeutic Plasma Exchange Market Challenges
Table 16. Therapeutic Plasma Exchange Market Restraints
Table 17. Global Therapeutic Plasma Exchange Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Therapeutic Plasma Exchange Market Share by Players (2016-2021)
Table 19. Global Top Therapeutic Plasma Exchange Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Plasma Exchange as of 2020)
Table 20. Ranking of Global Top Therapeutic Plasma Exchange Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Therapeutic Plasma Exchange Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Therapeutic Plasma Exchange Product Solution and Service
Table 24. Date of Enter into Therapeutic Plasma Exchange Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Therapeutic Plasma Exchange Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Therapeutic Plasma Exchange Revenue Market Share by Type (2016-2021)
Table 28. Global Therapeutic Plasma Exchange Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Therapeutic Plasma Exchange Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Therapeutic Plasma Exchange Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Therapeutic Plasma Exchange Revenue Market Share by Application (2016-2021)
Table 32. Global Therapeutic Plasma Exchange Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Therapeutic Plasma Exchange Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Therapeutic Plasma Exchange Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Therapeutic Plasma Exchange Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Therapeutic Plasma Exchange Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Therapeutic Plasma Exchange Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Therapeutic Plasma Exchange Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Therapeutic Plasma Exchange Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Therapeutic Plasma Exchange Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Therapeutic Plasma Exchange Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Therapeutic Plasma Exchange Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Therapeutic Plasma Exchange Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Therapeutic Plasma Exchange Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Therapeutic Plasma Exchange Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Therapeutic Plasma Exchange Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Therapeutic Plasma Exchange Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Therapeutic Plasma Exchange Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Therapeutic Plasma Exchange Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Therapeutic Plasma Exchange Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Therapeutic Plasma Exchange Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Therapeutic Plasma Exchange Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Therapeutic Plasma Exchange Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Therapeutic Plasma Exchange Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Therapeutic Plasma Exchange Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Therapeutic Plasma Exchange Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Therapeutic Plasma Exchange Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Therapeutic Plasma Exchange Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Therapeutic Plasma Exchange Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Therapeutic Plasma Exchange Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Therapeutic Plasma Exchange Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Therapeutic Plasma Exchange Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Therapeutic Plasma Exchange Market Size by Country (2022-2027) & (US$ Million)
Table 64. Asahi Kasei Corporation Company Details
Table 65. Asahi Kasei Corporation Business Overview
Table 66. Asahi Kasei Corporation Therapeutic Plasma Exchange Product
Table 67. Asahi Kasei Corporation Revenue in Therapeutic Plasma Exchange Business (2016-2021) & (US$ Million)
Table 68. Asahi Kasei Corporation Recent Development
Table 69. Baxter International Company Details
Table 70. Baxter International Business Overview
Table 71. Baxter International Therapeutic Plasma Exchange Product
Table 72. Baxter International Revenue in Therapeutic Plasma Exchange Business (2016-2021) & (US$ Million)
Table 73. Baxter International Recent Development
Table 74. Terumo Corporation Company Details
Table 75. Terumo Corporation Business Overview
Table 76. Terumo Corporation Therapeutic Plasma Exchange Product
Table 77. Terumo Corporation Revenue in Therapeutic Plasma Exchange Business (2016-2021) & (US$ Million)
Table 78. Terumo Corporation Recent Development
Table 79. B. Braun Company Details
Table 80. B. Braun Business Overview
Table 81. B. Braun Therapeutic Plasma Exchange Product
Table 82. B. Braun Revenue in Therapeutic Plasma Exchange Business (2016-2021) & (US$ Million)
Table 83. B. Braun Recent Development
Table 84. Fresenius Kabi Company Details
Table 85. Fresenius Kabi Business Overview
Table 86. Fresenius Kabi Therapeutic Plasma Exchange Product
Table 87. Fresenius Kabi Revenue in Therapeutic Plasma Exchange Business (2016-2021) & (US$ Million)
Table 88. Fresenius Kabi Recent Development
Table 89. Kawasumi Laboratories Company Details
Table 90. Kawasumi Laboratories Business Overview
Table 91. Kawasumi Laboratories Therapeutic Plasma Exchange Product
Table 92. Kawasumi Laboratories Revenue in Therapeutic Plasma Exchange Business (2016-2021) & (US$ Million)
Table 93. Kawasumi Laboratories Recent Development
Table 94. Haemonetics Corporation Company Details
Table 95. Haemonetics Corporation Business Overview
Table 96. Haemonetics Corporation Therapeutic Plasma Exchange Product
Table 97. Haemonetics Corporation Revenue in Therapeutic Plasma Exchange Business (2016-2021) & (US$ Million)
Table 98. Haemonetics Corporation Recent Development
Table 99. Cerus Corporation Company Details
Table 100. Cerus Corporation Business Overview
Table 101. Cerus Corporation Revenue in Therapeutic Plasma Exchange Business (2016-2021) & (US$ Million)
Table 102. Cerus Corporation Recent Development
Table 103. Hemacare Corporation Company Details
Table 104. Hemacare Corporation Business Overview
Table 105. Hemacare Corporation Therapeutic Plasma Exchange Product
Table 106. Hemacare Corporation Revenue in Therapeutic Plasma Exchange Business (2016-2021) & (US$ Million)
Table 107. Hemacare Corporation Recent Development
Table 108. Medica S.p.A. Company Details
Table 109. Medica S.p.A. Business Overview
Table 110. Medica S.p.A. Therapeutic Plasma Exchange Product
Table 111. Medica S.p.A. Revenue in Therapeutic Plasma Exchange Business (2016-2021) & (US$ Million)
Table 112. Medica S.p.A. Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Plasma Exchange Market Share by Type: 2020 VS 2027
Figure 2. Neurological Disorders Features
Figure 3. Renal Disorders Features
Figure 4. Hematology Disorders Features
Figure 5. Metabolic Disorders Features
Figure 6. Others Features
Figure 7. Global Therapeutic Plasma Exchange Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Therapeutic Plasma Exchange Report Years Considered
Figure 12. Global Therapeutic Plasma Exchange Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Therapeutic Plasma Exchange Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Therapeutic Plasma Exchange Market Share by Regions: 2020 VS 2027
Figure 15. Global Therapeutic Plasma Exchange Market Share by Regions (2022-2027)
Figure 16. Global Therapeutic Plasma Exchange Market Share by Players in 2020
Figure 17. Global Top Therapeutic Plasma Exchange Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Plasma Exchange as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Therapeutic Plasma Exchange Revenue in 2020
Figure 19. Global Therapeutic Plasma Exchange Revenue Market Share by Type (2016-2021)
Figure 20. Global Therapeutic Plasma Exchange Revenue Market Share by Type (2022-2027)
Figure 21. North America Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Therapeutic Plasma Exchange Market Share by Type (2016-2027)
Figure 23. North America Therapeutic Plasma Exchange Market Share by Application (2016-2027)
Figure 24. North America Therapeutic Plasma Exchange Market Share by Country (2016-2027)
Figure 25. United States Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Therapeutic Plasma Exchange Market Share by Type (2016-2027)
Figure 29. Europe Therapeutic Plasma Exchange Market Share by Application (2016-2027)
Figure 30. Europe Therapeutic Plasma Exchange Market Share by Country (2016-2027)
Figure 31. Germany Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Therapeutic Plasma Exchange Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Therapeutic Plasma Exchange Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Therapeutic Plasma Exchange Market Share by Region (2016-2027)
Figure 41. China Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Therapeutic Plasma Exchange Market Share by Type (2016-2027)
Figure 49. Latin America Therapeutic Plasma Exchange Market Share by Application (2016-2027)
Figure 50. Latin America Therapeutic Plasma Exchange Market Share by Country (2016-2027)
Figure 51. Mexico Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Therapeutic Plasma Exchange Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Therapeutic Plasma Exchange Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Therapeutic Plasma Exchange Market Share by Country (2016-2027)
Figure 57. Turkey Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Therapeutic Plasma Exchange Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Asahi Kasei Corporation Revenue Growth Rate in Therapeutic Plasma Exchange Business (2016-2021)
Figure 61. Baxter International Revenue Growth Rate in Therapeutic Plasma Exchange Business (2016-2021)
Figure 62. Terumo Corporation Revenue Growth Rate in Therapeutic Plasma Exchange Business (2016-2021)
Figure 63. B. Braun Revenue Growth Rate in Therapeutic Plasma Exchange Business (2016-2021)
Figure 64. Fresenius Kabi Revenue Growth Rate in Therapeutic Plasma Exchange Business (2016-2021)
Figure 65. Kawasumi Laboratories Revenue Growth Rate in Therapeutic Plasma Exchange Business (2016-2021)
Figure 66. Haemonetics Corporation Revenue Growth Rate in Therapeutic Plasma Exchange Business (2016-2021)
Figure 67. Cerus Corporation Revenue Growth Rate in Therapeutic Plasma Exchange Business (2016-2021)
Figure 68. Hemacare Corporation Revenue Growth Rate in Therapeutic Plasma Exchange Business (2016-2021)
Figure 69. Medica S.p.A. Revenue Growth Rate in Therapeutic Plasma Exchange Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---